International Drug Safety Monitoring
In the 1960s, following the Thalidomide Disaster, the World Health Organization (WHO) initiated the development of an international drug safety monitoring programme. The objectives of this WHO programme are to improve the quality and safety of pharmaceuticals, and to support public health programmes...
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | Russian |
| Julkaistu: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2019-09-01
|
| Sarja: | Безопасность и риск фармакотерапии |
| Aiheet: | |
| Linkit: | https://www.risksafety.ru/jour/article/view/151 |